BioCentury
ARTICLE | Clinical News

Provigil modafinil regulatory update

November 1, 2010 7:00 AM UTC

FDA approved a REMS for Provigil modafinil from Cephalon to inform patients about the potential risks associated with its use, including serious skin rash and hypersensitivity reactions. The REMS cons...